4.5 Article

Development of a US trust measure to assess and monitor parental confidence in the vaccine system

期刊

VACCINE
卷 37, 期 2, 页码 325-332

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2018.09.043

关键词

Vaccine confidence; Vaccine measurement; Vaccine index; Immunization coverage; Immunization assessment

资金

  1. National Vaccine Program Office [1VSRNV00000]
  2. National Institute for Allergy and Infectious Diseases, National Institutes of Health [K01Al106961]

向作者/读者索取更多资源

Objective: To develop a Vaccine Confidence Index (VCI) that is capable of detecting variations in parental confidence towards childhood immunizations centered on trust and concern issues that impact vaccine confidence. Methods: We used a web-based national poll of 893 parents of children <7 years in 2016 to assess the measures created for the Emory VCI (EVCI). EVCI measures were developed using constructs related to vaccine confidence identified by the U.S. National Vaccine Advisory Committee (i.e., Information Environment, Trust, Healthcare Provider, Attitudes and Beliefs, and Social Norms). Reliability for EVCI was assessed using Cronbach's alpha. Using the variables related to each of the constructs, we calculated an overall EVCI score that was then assessed against self-reported childhood vaccine receipt using chi-square and the Cochrane-Armitage trend tests. Results: Respondents' EVCI scores could range from 0 to 24, and the full range of values was observed in this sample (Mean = 17.5 (SD 4.8)). EVCI scores were significantly different (p <= 0.006 for all comparisons) between parents who indicated their child(ren) received routinely recommended vaccines compared with parents who indicated they had delayed or declined recommended immunizations. There was also a significant, consistent association between higher EVCI scores and greater reported vaccine receipt. Conclusions: We developed EVCI to reliably measure parental vaccine confidence, with individuals' scores linked to parental vaccine-related attitudes, intentions, and behaviors. As such, EVCI may be a useful tool for future monitoring of both population and individual confidence in childhood immunization. (C) 2018 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Clinical

Understanding the Factors Influencing Health Care Provider Recommendations about Adolescent Vaccines: A Proposed Framework

Mallory K. Ellingson, Robert A. Bednarczyk, Sean T. O'Leary, Jason L. Schwartz, Eugene D. Shapiro, Linda M. Niccolai

Summary: Health care provider recommendations play a crucial role in parents' decisions to vaccinate their adolescents. However, the delivery of high-quality recommendations for vaccination varies widely. Factors influencing providers' recommendations include attitudes and beliefs, patient characteristics, community context, and vaccine policies. A multi-level framework is proposed to understand and improve providers' recommendations.

JOURNAL OF BEHAVIORAL MEDICINE (2023)

Review Psychology, Developmental

Mental Health Impact of COVID-19 among Children and College Students: A Systematic Review

Jad A. Elharake, Faris Akbar, Amyn A. Malik, Walter Gilliam, Saad B. Omer

Summary: The COVID-19 pandemic has significantly impacted the mental health of children and college students, leading to increased anxiety, depression, fatigue, and distress. Factors such as living in rural areas, low family socioeconomic status, and having a connection to healthcare workers have been associated with worse mental health outcomes. Future strategies should prioritize social contacts to support students at higher risk of social isolation during the pandemic.

CHILD PSYCHIATRY & HUMAN DEVELOPMENT (2023)

Article Urology & Nephrology

Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension

Chia-shi Wang, Rinchen Doma, Adrianna L. Westbrook, Jillian Johnson, Evan J. Anderson, Larry A. Greenbaum, Shaheen A. Rana, Roshan P. George, Rouba Garro, Anjali Khanna-Farber, Cam Escoffery, Robert A. Bednarczyk

Summary: This study examined COVID-19 vaccine hesitancy among parents of children with chronic kidney disease or hypertension. The results showed that two-thirds of parents were unsure or unwilling to vaccinate their child against COVID-19. Additionally, hesitancy toward routine childhood and influenza vaccination was associated with hesitancy toward COVID-19 vaccines. Therefore, it is necessary to enhance communication of vaccine information relevant to kidney patients in an accessible manner to reduce vaccine hesitancy.

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Editorial Material Medicine, General & Internal

The legacy of the COVID-19 pandemic for childhood vaccination in the USA

Douglas J. Opel, Noel T. Brewer, Alison M. Buttenheim, Timothy Callaghan, Richard M. Carpiano, Chelsea Clinton, Jad A. Elharake, Lisa C. Flowers, Alison P. Galvani, Peter J. Hotez, Jason L. Schwartz, Regina M. Benjamin, Arthur Caplan, Renee DiResta, Rekha Lakshmanan, Yvonne A. Maldonado, Michelle M. Mello, Wendy E. Parmet, Daniel A. Salmon, Joshua M. Sharfstein, Saad B. Omer

LANCET (2023)

Article Immunology

Trends in vaccination schedules and up-to-date status of children 19-35 months, United States, 2015-2020

Kimberly H. Nguyen, Ruitong Zhao, Corey Mullins, Laura Corlin, Paul Beninger, Robert A. Bednarczyk

Summary: This study analyzed the vaccination patterns and factors associated with the immunization status of U.S. children aged 19 to 35 months. The study found that from 2015 to 2020, the proportion of children completing the recommended schedule increased, while the proportion following alternative or unknown schedules was lowest. Additionally, the percentage of children not up-to-date with vaccinations decreased. However, there was no change in the percentage of children receiving zero vaccinations. The study also found that lower-income or uninsured families were more likely to follow alternative or unknown schedules or not be up-to-date with vaccines. Therefore, increased efforts are needed to promote timely adherence to recommended vaccination schedules, especially among populations with significant disparities in coverage, through tailored approaches to increase confidence in and access to vaccines.

VACCINE (2023)

Article Immunology

Understanding the Impact of General Vaccine Attitudes on the Intent for Early COVID-19 Vaccination

John Boyle, Glen Nowak, Rachel Kinder, Ronaldo Iachan, James Dayton

Summary: Despite high rates of spread, morbidity and mortality, the uptake of COVID-19 vaccines among eligible populations has been slow. This study examines the factors influencing willingness to get an early vaccination and finds that general vaccine beliefs play a significant role, even compared to demographics, perceived risk, and institutional trust. The findings from this study can inform future public health communication strategies.

VACCINES (2023)

Article Evolutionary Biology

Nonsystematic Reporting Biases of the SARS-CoV-2 Variant Mu Could Impact Our Understanding of the Epidemiological Dynamics of Emerging Variants

Mary E. Petrone, Carolina Lucas, Bridget Menasche, Mallery Breban, Inci Yildirim, Melissa Campbell, Saad B. Omer, Edward C. Holmes, Albert Ko, Nathan D. Grubaugh, Akiko Iwasaki, Craig B. Wilen, Chantal B. F. Vogels, Joseph R. Fauver

Summary: Developing a timely and effective response to emerging SARS-CoV-2 variants of concern is crucial for public health. Global health surveillance relies not only on genomic data but also on methods that utilize genomic data to estimate the epidemiological dynamics of emerging lineages. In this study, the differences in reporting delays among SARS-CoV-2 VOCs were analyzed, indicating that these delays may have delayed the global response to the Mu variant. The nonsystematic biases in the reporting of genomic data could impede the assessment of future emerging variants.

GENOME BIOLOGY AND EVOLUTION (2023)

Article Immunology

Molnupiravir Use and 30-Day Hospitalizations or Death in a Previously Uninfected Nonhospitalized High-risk Population With COVID-19

Adeel A. Butt, Peng Yan, Obaid S. Shaikh, Saad B. Omer, Florian B. Mayr, Victor B. Talisa

Summary: In previously uninfected, nonhospitalized, high-risk persons with COVID-19, the use of molnupiravir does not significantly reduce the rate of hospitalization or death within 30 days of diagnosis. However, asymptomatic patients might experience a benefit.

JOURNAL OF INFECTIOUS DISEASES (2023)

Editorial Material Medicine, General & Internal

Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era

Richard M. Carpiano, Timothy Callaghan, Renee DiResta, Noel Brewer, Chelsea Clinton, Alison P. Galvani, Rekha Lakshmanan, Wendy E. Parmet, Saad B. Omer, Alison M. Buttenheim, Regina M. Benjamin, Arthur Caplan, Jad A. Elharake, Lisa C. Flowers, Yvonne A. Maldonado, Michelle M. Mello, Douglas J. Opel, Daniel A. Salmon, Jason L. Schwartz, Joshua M. Sharfstein, Peter J. Hotez

LANCET (2023)

Article Pediatrics

State of Vaccine Hesitancy in the United States

Glen J. Nowak, Michael A. Cacciatore

PEDIATRIC CLINICS OF NORTH AMERICA (2023)

Article Cell Biology

Age-dependent impairment in antibody responses elicited by a homologous CoronaVac booster dose

Bruno Andraus Filardi, Valter Silva Monteiro, Pedro Vellosa Schwartzmann, Vivian do Prado Martins, Luis Eduardo Rosa Zucca, Gabriela Crispim Baiocchi, Amyn A. Malik, Julio Silva, Anne M. Hahn, Nicholas F. G. Chen, Kien Pham, Eddy Perez-Then, Marija Miric, Vivian Brache, Leila Cochon, Rafael A. Larocca, Roberto Della Rosa Mendez, Douglas Bardini Silveira, Aguinaldo Roberto Pinto, Julio Croda, Inci Yildirim, Saad B. Omer, Albert I. Ko, Sten H. Vermund, Nathan D. Grubaugh, Akiko Iwasaki, Carolina Lucas

Summary: The emergence of the SARS-CoV-2 Omicron sublineages resulted in increased transmission rates and reduced vaccine protection. Homologous CoronaVac booster doses showed lower efficiency in enhancing immune response compared to heterologous BNT162b2 or ChAdOx1 boosters, especially in individuals over 50 years old. These findings emphasize the potential benefits of heterologous vaccination strategies for older adults fully vaccinated with CoronaVac during the Omicron wave.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Review Biotechnology & Applied Microbiology

Human papillomavirus vaccination at the first opportunity: An overview

Robert A. Bednarczyk, Noel T. Brewer, Melissa B. Gilkey, Sherri Zorn, Rebecca B. Perkins, Kristin Oliver, Debbie Saslow

Summary: The ACIP has recommended HPV vaccination for adolescents since 2006, but its uptake has lagged behind other adolescent vaccines. The ACIP recommends starting HPV vaccination at 11-12 y, with 9 y as an option. This commentary summarizes the current recommendations and evidence regarding HPV vaccination starting at 9 y, and suggests future directions for research and implementation.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Article Biotechnology & Applied Microbiology

Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen

Robert A. Bednarczyk, Heather M. Brandt

Summary: Despite being recommended for routine adolescent use, HPV vaccination uptake in the United States lags behind that of other vaccines such as Tdap and MCV4. Initiating the vaccine series at a younger age, as early as 9 years old, may help improve HPV vaccination rates. This study analyzed data from the NIS-Teen and found that 4.0% of US adolescents initiated HPV vaccination at 9-10 years old, with higher rates among younger birth cohorts. Completion rates for the vaccine series were highest after 3-4 years, with 93% of 13-year-olds completing the series after initiating at ages 9-10.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2023)

Article Immunology

Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis

Anis Barmada, Jon Klein, Anjali Ramaswamy, Nina N. Brodsky, Jillian R. Jaycox, Hassan Sheikha, Kate M. Jones, Victoria Habet, Melissa Campbell, Tomokazu S. Sumida, Amy Kontorovich, Dusan Bogunovic, Carlos R. Oliveira, Jeremy Steele, E. Kevin Hall, Mario Pena-Hernandez, Valter Monteiro, Carolina Lucas, Aaron M. Ring, Saad B. Omer, Akiko Iwasaki, Inci Yildirim, Carrie L. Lucas

Summary: A study found that rare immune-mediated cardiac tissue inflammation can occur after SARS-CoV-2 mRNA vaccination. Contrary to early hypotheses, the underlying mechanisms of this pathology do not involve hypersensitivity myocarditis or hyperimmune humoral response. Instead, elevated levels of inflammatory cytokines, chemokines, and matrix metalloproteases were observed, along with expansion of activated T cells and NK cells, and inflammation and fibrosis in monocytes. These findings provide insights into the cytokine-dependent pathology of vaccine-associated myopericarditis and have implications for vaccine development and clinical care.

SCIENCE IMMUNOLOGY (2023)

Article Public, Environmental & Occupational Health

COVID-19 Vaccine Acceptance and Hesitancy Among Health Care Workers in Lebanon

Nour J. Youssef, Nadim K. Tfaily, Mohammad Bahij M. Moumneh, Celina F. Boutros, Jad A. Elharake, Amyn A. Malik, SarahAnn M. McFadden, Bayan Galal, Inci Yildirim, Kaveh Khoshnood, Saad B. Omer, Ziad A. Memish, Ghassan S. Dbaibo

Summary: Lebanese healthcare workers show relatively high acceptance of the COVID-19 vaccine, but there are still barriers such as concerns about insufficient research. The WHO and healthcare providers are the most trusted sources of COVID-19 information. These findings are important for informing Lebanese health authorities in improving vaccine uptake.

JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH (2023)

暂无数据